GK-136901


CAS No. : 1062624-71-8

1062624-71-8
Price and Availability of CAS No. : 1062624-71-8
Size Price Stock
100 mg Get quote
250 mg Get quote
500 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-124487
M.Wt: 346.38
Formula: C20H18N4O2
Purity: >98 %
Solubility:
Introduction of 1062624-71-8 :

GK-136901 is an orally active, dual Nox1/Nox4 NADPH oxidase inhibitor with a Ki of 160 nM for Nox1 and 165 nM for Nox4. GK-136901 potently blocks high glucose-induced intracellular reactive oxygen species production, p38-MAPK phosphorylation, and upregulation of TGF-β1/2 and fibronectin (fibronectin) in renal cells. GK-136901 also inhibits the proliferation of mouse pulmonary vascular cells under hypoxic conditions. GK-136901 is applicable to the research on the pathogenesis of type 2 diabetic nephropathy, high glucose-related renal lesions and pulmonary hypertension[1][2][3][4]. In Vitro:GKT136901 (10 μM; 30 min) inhibits NADPH oxidase activity and ROS production induced by high D-glucose in MPT cells[2].
GKT136901 (10 μM; 30 min) inhibits the expression of profibrotic proteins and the activation of p38MAP kinase in MPT cells induced by high D-glucose[2]. In Vivo:GK-136901 attenuates hypoxia-induced pulmonary vascular cell proliferation in a mouse model of pulmonary arterial hypertension[4].
GK-136901 is well tolerated in mice, with oral administration doses tested up to 1000 mg/kg[5].

Your information is safe with us.